94 related articles for article (PubMed ID: 12873041)
1. Mitomycin C-induced renal insufficiency: a case report.
Wen MC; Chen CH; Ho WL
Kaohsiung J Med Sci; 2003 Jun; 19(6):317-21. PubMed ID: 12873041
[TBL] [Abstract][Full Text] [Related]
2. Glomerular tuft ballooning in mitomycin-C-induced renal impairment.
Shiiki H; Dohi K; Nishioka H; Matsuda T; Kanauchi M; Uyama H; Ishikawa H; Watanabe T
Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):545-51. PubMed ID: 1609513
[TBL] [Abstract][Full Text] [Related]
3. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
[TBL] [Abstract][Full Text] [Related]
5. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
[TBL] [Abstract][Full Text] [Related]
6. Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications.
Hagiwara A; Togawa T; Yamasaki J; Ohgaki M; Imanishi T; Shirasu M; Sakakura C; Yamaguchi T; Sawai K; Yamagishi H
Hepatogastroenterology; 1999; 46(27):1673-7. PubMed ID: 10430319
[TBL] [Abstract][Full Text] [Related]
7. [Mitomycin-induced hemolytic-uremic syndrome].
Zeller G; Wandel E; Schwarting A
Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1399-402. PubMed ID: 12813674
[TBL] [Abstract][Full Text] [Related]
8. [Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
Simon P; Hervé JP; Ramée MP; Leroy JP; Ang KS; Leguy P; Vignoud J; Cledes J
Nephrologie; 1982; 3(4):152-7. PubMed ID: 6818483
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Cantrell JE; Phillips TM; Schein PS
J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
[TBL] [Abstract][Full Text] [Related]
10. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
[TBL] [Abstract][Full Text] [Related]
12. Role of recombinant human erythropoietin against mitomycin C-induced cardiac, hepatic and renal dysfunction in Wistar rats.
Rjiba-Touati K; Ayed-Boussema I; Belarbia A; Mokni M; Achour A; Bacha H; Abid S
Hum Exp Toxicol; 2015 May; 34(5):468-78. PubMed ID: 25304971
[TBL] [Abstract][Full Text] [Related]
13. Silent renal microangiography after mitomycin C therapy.
Poch E; González-Clemente JM; Torras A; Darnell A; Botey A; Revert L
Am J Nephrol; 1990; 10(6):514-7. PubMed ID: 2127509
[TBL] [Abstract][Full Text] [Related]
14. [Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
Sagawa M; Sakuma T; Takahashi S; Usuda K; Satoh M; Kamma K; Ohta S; Nagamoto N; Imai T; Saitoh Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2564-7. PubMed ID: 3039922
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin-C induced hemolytic uremic syndrome: a case report.
Gundappa RK; Sud K; Kohli HS; Gupta KL; Joshi K; Sakhuja V
Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
Giroux L; Bettez P; Giroux L
Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
[TBL] [Abstract][Full Text] [Related]
17. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
18. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
[TBL] [Abstract][Full Text] [Related]
19. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of mitomycin C nephropathy.
Motoo Y; Sawabu N; Ikeda K; Takemori Y; Ohta H; Okai T; Yokoyama H
Intern Med; 1994 Mar; 33(3):180-4. PubMed ID: 8061399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
